Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis

We describe 27 children and adolescents <18 years of age who received bedaquiline during treatment for multidrug-resistant tuberculosis. We report good treatment responses and no cessation attributable to adverse effects. Bedaquiline could be considered for use with this age group for multidrug-r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Emerg Infect Dis
Main Authors: Achar, Jay, Hewison, Cathy, Cavalheiro, Ana P., Skrahina, Alena, Cajazeiro, Junia, Nargiza, Parpieva, Herboczek, Krzysztof, Rajabov, Assliddin S., Hughes, Jennifer, Ferlazzo, Gabriella, Seddon, James A., du Cros, Philipp
Formato: Artigo
Idioma:Inglês
Publicado em: Centers for Disease Control and Prevention 2017
Assuntos:
Dispatch
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5621552/
https://ncbi.nlm.nih.gov/pubmed/28758889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2310.170303
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados